107 related articles for article (PubMed ID: 32783433)
1. Medicine wastage in a thromboprophylaxis protocol for ambulatory trauma patients.
Mower S; Thompson S
Emerg Nurse; 2020 Nov; 28(6):35-40. PubMed ID: 32783433
[TBL] [Abstract][Full Text] [Related]
2. A Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention.
Revankar N; Patterson J; Kadambi A; Raymond V; El-Hadi W
Postgrad Med; 2013 Jul; 125(4):141-53. PubMed ID: 23933902
[TBL] [Abstract][Full Text] [Related]
3. Thromboprophylaxis in Ambulatory Trauma Patients With Foot and Ankle Fractures: Prospective Study Using a Risk Scoring System.
Haque S; Bishnoi A; Khairandish H; Menon D
Foot Ankle Spec; 2016 Oct; 9(5):388-93. PubMed ID: 27044599
[TBL] [Abstract][Full Text] [Related]
4. Economic impact of enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in patients with acute ischemic stroke: a hospital perspective of the PREVAIL trial.
Pineo G; Lin J; Stern L; Subrahmanian T; Annemans L
J Hosp Med; 2012 Mar; 7(3):176-82. PubMed ID: 22058011
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery.
Wolowacz SE; Roskell NS; Maciver F; Beard SM; Robinson PA; Plumb JM; Dolan G; Brenkel IJ
Clin Ther; 2009 Jan; 31(1):194-212. PubMed ID: 19243718
[TBL] [Abstract][Full Text] [Related]
6. The cost of outpatient venous thromboembolism prophylaxis following lower limb injuries.
Menakaya CU; Pennington N; Muthukumar N; Joel J; Ramirez Jimenez AJ; Shaw CJ; Mohsen A
Bone Joint J; 2013 May; 95-B(5):673-7. PubMed ID: 23632680
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis Comparing the Efficacy, Safety, and Cost-Benefit of Direct Acting Oral Anticoagulants Versus Enoxaparin Thromboprophylaxis to Prevent Venous Thromboembolism Among Hospitalized Patients.
Bhalla V; Abdel-Latif A; Bhalla M; Ziada K; Williams MV; Smyth SS
Am J Cardiol; 2018 Oct; 122(7):1236-1243. PubMed ID: 30082040
[TBL] [Abstract][Full Text] [Related]
8. Is extended thromboprophylaxis necessary in elective colorectal cancer surgery?
Chandra R; Melino G; Thomas M; Lawrence MJ; Hunter RA; Moore J
ANZ J Surg; 2013 Dec; 83(12):968-72. PubMed ID: 23802729
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based guidelines for thromboprophylaxis in patients with lower limb trauma requiring immobilization: an urgent, unmet need.
Douillet D; Penaloza A; Horner D; Savary D; Hugli O; Nemeth B; Chocron R; Tazarourte K; Roy PM
Eur J Emerg Med; 2020 Aug; 27(4):245-246. PubMed ID: 32618770
[No Abstract] [Full Text] [Related]
10. [The use of parnaparin sodium (Fluxum) in the prevention of thromboembolic complications after surgical treatment of fractures associated with high risks of thrombosis].
Kaplunov OA; Kaplunov KO
Khirurgiia (Mosk); 2020; (10):73-78. PubMed ID: 33047589
[TBL] [Abstract][Full Text] [Related]
11. Oral thromboprophylaxis in patients with ankle fractures immobilized in a below the knee cast.
Haque S; Davies MB
Foot Ankle Surg; 2015 Dec; 21(4):266-8. PubMed ID: 26564729
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Drug Wastage in the Operating Rooms and Intensive Care Units of a Regional Health Service.
Barbariol F; Deana C; Lucchese F; Cataldi G; Bassi F; Bove T; Vetrugno L; De Monte A
Anesth Analg; 2021 May; 132(5):1450-1456. PubMed ID: 33667211
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Extended Thromboprophylaxis in Patients Undergoing Colorectal Surgery from a Canadian Health Care System Perspective.
Trepanier M; Alhassan N; Sabapathy CA; Liberman AS; Charlebois P; Stein BL; S Feldman L; Lee L
Dis Colon Rectum; 2019 Nov; 62(11):1381-1389. PubMed ID: 31318768
[TBL] [Abstract][Full Text] [Related]
14. A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting.
Bao Y; Zhao G; Qu S; Xiong T; Yao X; Wu B
Clin Drug Investig; 2020 Feb; 40(2):161-171. PubMed ID: 31773492
[TBL] [Abstract][Full Text] [Related]
15. Gold Medal Forum Winner. Unfractionated heparin three times a day versus enoxaparin in the prevention of deep vein thrombosis in trauma patients.
Arnold JD; Dart BW; Barker DE; Maxwell RA; Burkholder HC; Mejia VA; Smith PW; Longley JM
Am Surg; 2010 Jun; 76(6):563-70. PubMed ID: 20583509
[TBL] [Abstract][Full Text] [Related]
16. The role of clinically significant venous thromboembolism and thromboprophylaxis in pediatric patients with pelvic or femoral fractures.
Greenwald LJ; Yost MT; Sponseller PD; Abdullah F; Ziegfeld SM; Ain MC
J Pediatr Orthop; 2012 Jun; 32(4):357-61. PubMed ID: 22584835
[TBL] [Abstract][Full Text] [Related]
17. Short-term therapy with enoxaparin or unfractionated heparin for venous thromboembolism in hospitalized patients: utilization study and cost-minimization analysis.
Argenta C; Ferreira MA; Sander GB; Moreira LB
Value Health; 2011; 14(5 Suppl 1):S89-92. PubMed ID: 21839908
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism risk stratification for patients with lower limb trauma and cast or brace immobilization.
Douillet D; Nemeth B; Penaloza A; Le Gal G; Moumneh T; Cannegieter SC; Roy PM
PLoS One; 2019; 14(6):e0217748. PubMed ID: 31220097
[TBL] [Abstract][Full Text] [Related]
19. Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin.
Pariser JJ; Pearce SM; Anderson BB; Packiam VT; Prachand VN; Smith ND; Steinberg GD
J Urol; 2017 Feb; 197(2):302-307. PubMed ID: 27569434
[TBL] [Abstract][Full Text] [Related]
20. Economic Evaluation of Rivaroxaban Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Knee Replacement and Total Hip Replacement: A Systematic Review.
Rashki Kemmak A; Abutorabi A; Alipour V
Clin Drug Investig; 2020 Aug; 40(8):715-725. PubMed ID: 32578155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
